Skip to main content
Premium Trial:

Request an Annual Quote

GenoLogics Raises $5M in VC Round

NEW YORK (GenomeWeb News) – Victoria, BC-based GenoLogics has raised $5 million in a private round of financing with venture capital investors.

The bioinformatics firm said that proceeds would be used to fund its ongoing expansion plans and to accelerate development and global deployment of an end-to-end informatics solution for organizations pursuing translational research initiatives.

Seattle-based OVP Venture Partners led the round of financing with additional investment from Growth Works and Yaletown Venture Partners of Vancouver.

"We've already seen GenoLogics make significant inroads by establishing collaborative partnerships with leading organizations that are looking for ways to achieve their translational research outcomes," said Chad Waite, managing director at OVP, in a statement.

Filed under

The Scan

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.

Study Offers Insights Into Role of Structural Variants in Cancer

A new study in Nature using cell lines shows that structural variants can enable oncogene activation.

Computer Model Uses Genetics, Health Data to Predict Mental Disorders

A new model in JAMA Psychiatry finds combining genetic and health record data can predict a mental disorder diagnosis before one is made clinically.

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.